Tyler and Cameron Winklevoss talk Bitcoin, security and Mark Zuckerberg.» Read More
The latest JOLTS survey shows we're suffering from a lack of qualified workers.
Yahoo will likely go ahead with the spin-off of its ownership stake in Alibaba, but that the company may be considering a reverse spin.
Jeb Bush tells CNBC his tax plan would help fuel growth by empowering Americans and creating an environment for investment.
The quality of presidential candidates paints a bearish picture for U.S. stocks, says the market prognosticator known as Dr. Doom.
U.S. crude settled down 11 cents on Tuesday at $45.94 a barrel but has dipped below $40 a barrel in the last month.
Matthew Roden of UBS weighs in on the cost of cholesterol drugs. Roden upgraded both Amgen and Regeneron, two companies that produce the drugs.
CNBC's Deirdre Bosa uses Kensho data to determine what may happen to stocks this month.
Jeff Kilburg, Founder & CEO, KKM Financial, discusses the WSJ story about a hedge fund manager, Jeffrey Talpins, whose Element Capital, is buying billions of dollars worth of US Treasurys.
"Power Lunch" hosts Melissa Lee and Brian Sullivan look at 5 stocks with analyst recommendations, including Regeneron and Micron.
Ari Wald, Oppenheimer & Co., and Boris Schlossberg, BK Asset Management, discuss one of Warren Buffett's favorite energy names, including Phillips 66.
CNBC's Jackie DeAngelis reports on energy prices at the close.
Sand storms rage across the Middle East, and Japanese Prime Minister Shinzo Abe was re-elected president of the ruling Liberal Democratic Party. CNBC's Sue Herera reports.
CNBC's Dominic Chu looks at what happens to Apple's stock price around events like the one slated for tomorrow.
CNBC's Josh Lipton previews tomorrow's Apple event.
Blue jeans, Baby!
What to buy in biotech
Vanity Fair's Top tech disruptors
Ross DeVol, Chief Research Officer, Milken Institute, says you shouldn't confuse the crazy markets with the US economy.
Larry McDonald, Societe Generale, discusses the decline in global market capitalization over the last three months and what it means to stocks.
Discussing some of the most beaten up names in the correction, and market forecasts, with Kenny Polcari, O'Neil Securities.